Stanley-Laman Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-39,278
Closed -$1.1M 226
2017
Q1
$1.1M Buy
39,278
+8,724
+29% +$229K 0.3% 95
2016
Q4
$746K Buy
30,554
+1,123
+4% +$25.7K 0.23% 134
2016
Q3
$741K Sell
29,431
-238,922
-89% -$5.72M 0.3% 119
2016
Q2
$5.54M Buy
268,353
+30,927
+13% +$645K 2.16% 5
2016
Q1
$4.77M Buy
+237,426
New +$4.55M 0.9% 32

Other funds holding SBRA

Stanley-Laman Group's SBRA Position: Q2 2017 in Review

Stanley-Laman Group sold out of Sabra Healthcare REIT (SBRA) in Q2 2017, closing a stake of 39,278 shares — an estimated $1.1M sold.

Stanley-Laman Group first reported a position in SBRA in Q1 2016 and held it in 5 quarters. The position peaked at $5.54M in Q2 2016. 220 funds tracked by Wall St. Rank hold SBRA as of Q2 2017.

  • Stanley-Laman Group reported no remaining Sabra Healthcare REIT position as of Q2 2017 after selling out during the quarter.
  • Stanley-Laman Group sold 39,278 Sabra Healthcare REIT shares in Q2 2017, an estimated $1.1M.
  • Stanley-Laman Group first reported a position in Sabra Healthcare REIT in Q1 2016 and held it in 5 quarters.
  • Stanley-Laman Group's Sabra Healthcare REIT position peaked at $5.54M in Q2 2016.
  • 220 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2017.

Based on Stanley-Laman Group's 13F filing for Q2 2017, filed 7 Aug 2017.